Otsuka

SMARTMEDICINE

Marketer for Otsuka
ponatinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA05 - ponatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in